AKOS BC-2516
|
- $250 - $874
- Product name: AKOS BC-2516
- CAS: 869949-38-2
- MF: C11H12ClNO3
- MW: 241.67
- EINECS:
- MDL Number:MFCD09036957
- Synonyms:AKOS BC-2516;2-Chloro-5-morpholin-4-yl-benzoic acid;2-chloro-5-morpholinobenzoic acid;Benzoic acid, 2-chloro-5-(4-morpholinyl)-;2-Chloro-5-(4-morpholinyl)benzoic acid
4 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0039586
- Product description2-CHLORO-5-MORPHOLIN-4-YL-BENZOIC ACID 95.00%
- Packaging500MG
- Price$796.95
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11040213
- Product description2-Chloro-5-morpholinobenzoicacid 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number033852
- Product description2-Chloro-5-morpholin-4-yl-benzoic acid
- Packaging1g
- Price$385
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number033852
- Product description2-Chloro-5-morpholin-4-yl-benzoic acid
- Packaging500mg
- Price$250
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0039586 | 2-CHLORO-5-MORPHOLIN-4-YL-BENZOIC ACID 95.00% | 500MG | $796.95 | 2021-12-16 | Buy |
| Crysdot | CD11040213 | 2-Chloro-5-morpholinobenzoicacid 97% | 5g | $874 | 2021-12-16 | Buy |
| Matrix Scientific | 033852 | 2-Chloro-5-morpholin-4-yl-benzoic acid | 1g | $385 | 2021-12-16 | Buy |
| Matrix Scientific | 033852 | 2-Chloro-5-morpholin-4-yl-benzoic acid | 500mg | $250 | 2021-12-16 | Buy |
Properties
Boiling point :454.3±45.0 °C(Predicted)
Density :1.363±0.06 g/cm3(Predicted)
pka :2.19±0.25(Predicted)
Density :1.363±0.06 g/cm3(Predicted)
pka :2.19±0.25(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|